NEW YORK (TheStreet) -- RATINGS CHANGES
Big Lots(BIG) - Get Report was initiated with a hold rating at Cantor Fitzgerald. Twelve-month price target is $44. Big Lots is implementing multiple initiatives that leave analysts with a positive longer-term bias (initiatives such as reviving same-store sales), but they do not expect to see an immediate payoff, Cantor Fitzgerald said.
Finish Line (FINL) was upgraded at Janney to buy from neutral. Twelve-month price target is $30. Company is seeing momentum with digital sales and its Macy's(M) - Get Report partnership and will likely buy back more stock, Janney said.
HollyFrontier(HFC) - Get Report was upgraded at RBC Capital Markets to outperform from sector perform. Twelve-month price target is $49. Analysts previously saw HFC as more of a trading name, and their concerns were poor operational execution, little master limited partnership drop potential, a likely cut in the special dividend, no regular repurchase program and a likely degradation of HFC's peer-leading margins, RBC Capital Markets said. HFC has now addressed the first four concerns, and the fifth has come in better than expected, RBC Capital Markets added.
Infinity Pharmaceuticals(INFI) - Get Report was initiated with a buy rating at Deutsche Bank. Twelve-month price target is $20. Small-cap stock to own for long-term capital appreciation, Deutsche Bank said. Infinity is developing Duvelisib in various blood cancers, Deutsche Bank said.
OraSure Technologies(OSUR) - Get Report was downgraded at JMP Securities to market perform from market outperform. Twelve-month price target is $10. Analysts believe the domestic HIV business will continue to be pressured by competition and the shift toward more accurate and automated technologies, JMP Securities said.
Taser (TASR) was downgraded at Oppenheimer to perform from outperform. Valuation call, as the stock is up 42% since early April, Oppenheimer said.
Whole Foods Market (WFM) was upgraded at RBC Capital Markets to outperform from sector perform. Twelve-month price target is $51. With easing prior-year comps, acceleration of the cumulative effects of store refreshes, and stabilizing employee outlook, analysts believe comparable store sales growth has bottomed, RBC Capital Markets said.
Editor's note: To see analysts' stock comments and changes to price targets and earnings estimates, go to "Street Notes," which is available only to Real Money subscribers. To find out how to become a subscriber, please click here.
This article was written by a staff member of TheStreet.